nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—CYP3A4—Rivastigmine—Alzheimer's disease	0.21	0.432	CbGbCtD
Methylprednisolone—CYP3A4—Donepezil—Alzheimer's disease	0.168	0.345	CbGbCtD
Methylprednisolone—CYP3A4—Galantamine—Alzheimer's disease	0.108	0.223	CbGbCtD
Methylprednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR6—Alzheimer's disease	0.0022	0.0465	CbGpPWpGaD
Methylprednisolone—ABCB1—ABC-family proteins mediated transport—ABCA7—Alzheimer's disease	0.00157	0.0332	CbGpPWpGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TTR—Alzheimer's disease	0.00154	0.0325	CbGpPWpGaD
Methylprednisolone—Cardiac failure—Memantine—Alzheimer's disease	0.00147	0.00318	CcSEcCtD
Methylprednisolone—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00144	0.00311	CcSEcCtD
Methylprednisolone—Bradycardia—Galantamine—Alzheimer's disease	0.00144	0.00311	CcSEcCtD
Methylprednisolone—Osteoarthritis—Memantine—Alzheimer's disease	0.00144	0.00311	CcSEcCtD
Methylprednisolone—Haemoglobin—Galantamine—Alzheimer's disease	0.00142	0.00307	CcSEcCtD
Methylprednisolone—Rhinitis—Galantamine—Alzheimer's disease	0.00142	0.00306	CcSEcCtD
Methylprednisolone—Affect lability—Memantine—Alzheimer's disease	0.00142	0.00306	CcSEcCtD
Methylprednisolone—Haemorrhage—Galantamine—Alzheimer's disease	0.00141	0.00305	CcSEcCtD
Methylprednisolone—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.00141	0.00304	CcSEcCtD
Methylprednisolone—Hallucination—Galantamine—Alzheimer's disease	0.00141	0.00304	CcSEcCtD
Methylprednisolone—Psychotic disorder—Memantine—Alzheimer's disease	0.00141	0.00303	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.0014	0.00302	CcSEcCtD
Methylprednisolone—Muscular weakness—Donepezil—Alzheimer's disease	0.0014	0.00302	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00139	0.003	CcSEcCtD
Methylprednisolone—Affect lability—Rivastigmine—Alzheimer's disease	0.00139	0.00299	CcSEcCtD
Methylprednisolone—ABCB1—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.00138	0.0292	CbGpPWpGaD
Methylprednisolone—Abdominal distension—Donepezil—Alzheimer's disease	0.00138	0.00298	CcSEcCtD
Methylprednisolone—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00137	0.00297	CcSEcCtD
Methylprednisolone—Irritability—Memantine—Alzheimer's disease	0.00137	0.00296	CcSEcCtD
Methylprednisolone—Cardiac arrest—Memantine—Alzheimer's disease	0.00137	0.00295	CcSEcCtD
Methylprednisolone—Visual impairment—Galantamine—Alzheimer's disease	0.00136	0.00294	CcSEcCtD
Methylprednisolone—Mood swings—Memantine—Alzheimer's disease	0.00136	0.00294	CcSEcCtD
Methylprednisolone—Pancreatitis—Donepezil—Alzheimer's disease	0.00134	0.0029	CcSEcCtD
Methylprednisolone—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00134	0.00289	CcSEcCtD
Methylprednisolone—Sweating increased—Donepezil—Alzheimer's disease	0.00133	0.00288	CcSEcCtD
Methylprednisolone—Mood swings—Rivastigmine—Alzheimer's disease	0.00133	0.00288	CcSEcCtD
Methylprednisolone—Eye disorder—Galantamine—Alzheimer's disease	0.00132	0.00285	CcSEcCtD
Methylprednisolone—Cardiac disorder—Galantamine—Alzheimer's disease	0.00131	0.00283	CcSEcCtD
Methylprednisolone—Angiopathy—Galantamine—Alzheimer's disease	0.00128	0.00277	CcSEcCtD
Methylprednisolone—Immune system disorder—Galantamine—Alzheimer's disease	0.00128	0.00276	CcSEcCtD
Methylprednisolone—Breast disorder—Rivastigmine—Alzheimer's disease	0.00127	0.00275	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00127	0.00274	CcSEcCtD
Methylprednisolone—Muscular weakness—Memantine—Alzheimer's disease	0.00127	0.00274	CcSEcCtD
Methylprednisolone—Arrhythmia—Galantamine—Alzheimer's disease	0.00126	0.00273	CcSEcCtD
Methylprednisolone—Weight increased—Donepezil—Alzheimer's disease	0.00125	0.00269	CcSEcCtD
Methylprednisolone—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00124	0.00268	CcSEcCtD
Methylprednisolone—Mental disorder—Galantamine—Alzheimer's disease	0.00124	0.00267	CcSEcCtD
Methylprednisolone—Malnutrition—Galantamine—Alzheimer's disease	0.00123	0.00266	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—CELF1—Alzheimer's disease	0.00123	0.026	CbGpPWpGaD
Methylprednisolone—Bronchospasm—Memantine—Alzheimer's disease	0.00122	0.00264	CcSEcCtD
Methylprednisolone—Infestation NOS—Donepezil—Alzheimer's disease	0.00122	0.00264	CcSEcCtD
Methylprednisolone—Infestation—Donepezil—Alzheimer's disease	0.00122	0.00264	CcSEcCtD
Methylprednisolone—Pancreatitis—Memantine—Alzheimer's disease	0.00122	0.00263	CcSEcCtD
Methylprednisolone—Sweating increased—Memantine—Alzheimer's disease	0.00121	0.00261	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.0012	0.0026	CcSEcCtD
Methylprednisolone—Myocardial infarction—Donepezil—Alzheimer's disease	0.0012	0.00258	CcSEcCtD
Methylprednisolone—Bronchospasm—Rivastigmine—Alzheimer's disease	0.0012	0.00258	CcSEcCtD
Methylprednisolone—Pancreatitis—Rivastigmine—Alzheimer's disease	0.00119	0.00257	CcSEcCtD
Methylprednisolone—Sweating increased—Rivastigmine—Alzheimer's disease	0.00119	0.00256	CcSEcCtD
Methylprednisolone—Sweating—Donepezil—Alzheimer's disease	0.00117	0.00253	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—PPP5C—Alzheimer's disease	0.00115	0.0243	CbGpPWpGaD
Methylprednisolone—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00114	0.00247	CcSEcCtD
Methylprednisolone—Weight increased—Memantine—Alzheimer's disease	0.00113	0.00244	CcSEcCtD
Methylprednisolone—Bradycardia—Donepezil—Alzheimer's disease	0.00112	0.00241	CcSEcCtD
Methylprednisolone—Malaise—Galantamine—Alzheimer's disease	0.00111	0.0024	CcSEcCtD
Methylprednisolone—Infestation—Memantine—Alzheimer's disease	0.00111	0.00239	CcSEcCtD
Methylprednisolone—Infestation NOS—Memantine—Alzheimer's disease	0.00111	0.00239	CcSEcCtD
Methylprednisolone—Weight increased—Rivastigmine—Alzheimer's disease	0.00111	0.00239	CcSEcCtD
Methylprednisolone—Vertigo—Galantamine—Alzheimer's disease	0.00111	0.00239	CcSEcCtD
Methylprednisolone—Syncope—Galantamine—Alzheimer's disease	0.0011	0.00238	CcSEcCtD
Methylprednisolone—Haemoglobin—Donepezil—Alzheimer's disease	0.0011	0.00238	CcSEcCtD
Methylprednisolone—Rhinitis—Donepezil—Alzheimer's disease	0.0011	0.00237	CcSEcCtD
Methylprednisolone—Haemorrhage—Donepezil—Alzheimer's disease	0.0011	0.00237	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00109	0.00236	CcSEcCtD
Methylprednisolone—Hallucination—Donepezil—Alzheimer's disease	0.00109	0.00235	CcSEcCtD
Methylprednisolone—Myocardial infarction—Memantine—Alzheimer's disease	0.00109	0.00235	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00109	0.00235	CcSEcCtD
Methylprednisolone—Infestation—Rivastigmine—Alzheimer's disease	0.00108	0.00234	CcSEcCtD
Methylprednisolone—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00108	0.00234	CcSEcCtD
Methylprednisolone—Loss of consciousness—Galantamine—Alzheimer's disease	0.00108	0.00234	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00107	0.00231	CcSEcCtD
Methylprednisolone—Convulsion—Galantamine—Alzheimer's disease	0.00107	0.0023	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00106	0.00229	CcSEcCtD
Methylprednisolone—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00106	0.00229	CcSEcCtD
Methylprednisolone—Hypertension—Galantamine—Alzheimer's disease	0.00106	0.00229	CcSEcCtD
Methylprednisolone—Visual impairment—Donepezil—Alzheimer's disease	0.00106	0.00228	CcSEcCtD
Methylprednisolone—Arthralgia—Galantamine—Alzheimer's disease	0.00105	0.00226	CcSEcCtD
Methylprednisolone—Myalgia—Galantamine—Alzheimer's disease	0.00105	0.00226	CcSEcCtD
Methylprednisolone—Anxiety—Galantamine—Alzheimer's disease	0.00104	0.00225	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00104	0.00225	CcSEcCtD
Methylprednisolone—Sweating—Rivastigmine—Alzheimer's disease	0.00104	0.00224	CcSEcCtD
Methylprednisolone—Discomfort—Galantamine—Alzheimer's disease	0.00104	0.00224	CcSEcCtD
Methylprednisolone—Confusional state—Galantamine—Alzheimer's disease	0.00101	0.00219	CcSEcCtD
Methylprednisolone—Bradycardia—Memantine—Alzheimer's disease	0.00101	0.00219	CcSEcCtD
Methylprednisolone—Haemoglobin—Memantine—Alzheimer's disease	0.001	0.00216	CcSEcCtD
Methylprednisolone—Rhinitis—Memantine—Alzheimer's disease	0.000998	0.00215	CcSEcCtD
Methylprednisolone—Haemorrhage—Memantine—Alzheimer's disease	0.000996	0.00215	CcSEcCtD
Methylprednisolone—Bradycardia—Rivastigmine—Alzheimer's disease	0.000992	0.00214	CcSEcCtD
Methylprednisolone—ABCB1—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000991	0.021	CbGpPWpGaD
Methylprednisolone—Hallucination—Memantine—Alzheimer's disease	0.000991	0.00214	CcSEcCtD
Methylprednisolone—Shock—Galantamine—Alzheimer's disease	0.000989	0.00213	CcSEcCtD
Methylprednisolone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000986	0.00213	CcSEcCtD
Methylprednisolone—Tachycardia—Galantamine—Alzheimer's disease	0.000981	0.00212	CcSEcCtD
Methylprednisolone—Arrhythmia—Donepezil—Alzheimer's disease	0.00098	0.00211	CcSEcCtD
Methylprednisolone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000979	0.00211	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Memantine—Alzheimer's disease	0.000978	0.00211	CcSEcCtD
Methylprednisolone—Rhinitis—Rivastigmine—Alzheimer's disease	0.000976	0.00211	CcSEcCtD
Methylprednisolone—Skin disorder—Galantamine—Alzheimer's disease	0.000976	0.00211	CcSEcCtD
Methylprednisolone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000974	0.0021	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000972	0.0021	CcSEcCtD
Methylprednisolone—Hallucination—Rivastigmine—Alzheimer's disease	0.000969	0.00209	CcSEcCtD
Methylprednisolone—Mental disorder—Donepezil—Alzheimer's disease	0.000961	0.00207	CcSEcCtD
Methylprednisolone—Visual impairment—Memantine—Alzheimer's disease	0.000959	0.00207	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000957	0.00207	CcSEcCtD
Methylprednisolone—Erythema—Donepezil—Alzheimer's disease	0.000955	0.00206	CcSEcCtD
Methylprednisolone—Malnutrition—Donepezil—Alzheimer's disease	0.000955	0.00206	CcSEcCtD
Methylprednisolone—Hypotension—Galantamine—Alzheimer's disease	0.000939	0.00203	CcSEcCtD
Methylprednisolone—Visual impairment—Rivastigmine—Alzheimer's disease	0.000939	0.00203	CcSEcCtD
Methylprednisolone—Eye disorder—Memantine—Alzheimer's disease	0.00093	0.00201	CcSEcCtD
Methylprednisolone—Cardiac disorder—Memantine—Alzheimer's disease	0.000924	0.00199	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000916	0.00198	CcSEcCtD
Methylprednisolone—Eye disorder—Rivastigmine—Alzheimer's disease	0.00091	0.00196	CcSEcCtD
Methylprednisolone—Insomnia—Galantamine—Alzheimer's disease	0.000909	0.00196	CcSEcCtD
Methylprednisolone—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000904	0.00195	CcSEcCtD
Methylprednisolone—Angiopathy—Memantine—Alzheimer's disease	0.000903	0.00195	CcSEcCtD
Methylprednisolone—Paraesthesia—Galantamine—Alzheimer's disease	0.000903	0.00195	CcSEcCtD
Methylprednisolone—Immune system disorder—Memantine—Alzheimer's disease	0.000899	0.00194	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Memantine—Alzheimer's disease	0.000897	0.00194	CcSEcCtD
Methylprednisolone—Arrhythmia—Memantine—Alzheimer's disease	0.000889	0.00192	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000886	0.00191	CcSEcCtD
Methylprednisolone—Dyspepsia—Galantamine—Alzheimer's disease	0.000885	0.00191	CcSEcCtD
Methylprednisolone—Angiopathy—Rivastigmine—Alzheimer's disease	0.000884	0.00191	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000878	0.00189	CcSEcCtD
Methylprednisolone—Mental disorder—Memantine—Alzheimer's disease	0.000872	0.00188	CcSEcCtD
Methylprednisolone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00087	0.00188	CcSEcCtD
Methylprednisolone—Malnutrition—Memantine—Alzheimer's disease	0.000867	0.00187	CcSEcCtD
Methylprednisolone—Fatigue—Galantamine—Alzheimer's disease	0.000867	0.00187	CcSEcCtD
Methylprednisolone—Malaise—Donepezil—Alzheimer's disease	0.000861	0.00186	CcSEcCtD
Methylprednisolone—Vertigo—Donepezil—Alzheimer's disease	0.000858	0.00185	CcSEcCtD
Methylprednisolone—Syncope—Donepezil—Alzheimer's disease	0.000856	0.00185	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—Alzheimer's disease	0.000854	0.0181	CbGpPWpGaD
Methylprednisolone—Mental disorder—Rivastigmine—Alzheimer's disease	0.000853	0.00184	CcSEcCtD
Methylprednisolone—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.00085	0.018	CbGpPWpGaD
Methylprednisolone—Malnutrition—Rivastigmine—Alzheimer's disease	0.000848	0.00183	CcSEcCtD
Methylprednisolone—Erythema—Rivastigmine—Alzheimer's disease	0.000848	0.00183	CcSEcCtD
Methylprednisolone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000839	0.00181	CcSEcCtD
Methylprednisolone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000828	0.00179	CcSEcCtD
Methylprednisolone—Convulsion—Donepezil—Alzheimer's disease	0.000827	0.00178	CcSEcCtD
Methylprednisolone—Hypertension—Donepezil—Alzheimer's disease	0.000824	0.00178	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000822	0.00177	CcSEcCtD
Methylprednisolone—Myalgia—Donepezil—Alzheimer's disease	0.000813	0.00175	CcSEcCtD
Methylprednisolone—Arthralgia—Donepezil—Alzheimer's disease	0.000813	0.00175	CcSEcCtD
Methylprednisolone—Anxiety—Donepezil—Alzheimer's disease	0.00081	0.00175	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Memantine—Alzheimer's disease	0.000804	0.00174	CcSEcCtD
Methylprednisolone—Discomfort—Donepezil—Alzheimer's disease	0.000803	0.00173	CcSEcCtD
Methylprednisolone—Abdominal pain—Galantamine—Alzheimer's disease	0.000795	0.00171	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000787	0.0017	CcSEcCtD
Methylprednisolone—Confusional state—Donepezil—Alzheimer's disease	0.000785	0.00169	CcSEcCtD
Methylprednisolone—Malaise—Memantine—Alzheimer's disease	0.000782	0.00169	CcSEcCtD
Methylprednisolone—Vertigo—Memantine—Alzheimer's disease	0.000779	0.00168	CcSEcCtD
Methylprednisolone—Syncope—Memantine—Alzheimer's disease	0.000777	0.00168	CcSEcCtD
Methylprednisolone—Infection—Donepezil—Alzheimer's disease	0.000774	0.00167	CcSEcCtD
Methylprednisolone—Shock—Donepezil—Alzheimer's disease	0.000766	0.00165	CcSEcCtD
Methylprednisolone—Malaise—Rivastigmine—Alzheimer's disease	0.000765	0.00165	CcSEcCtD
Methylprednisolone—Nervous system disorder—Donepezil—Alzheimer's disease	0.000764	0.00165	CcSEcCtD
Methylprednisolone—Vertigo—Rivastigmine—Alzheimer's disease	0.000762	0.00164	CcSEcCtD
Methylprednisolone—Loss of consciousness—Memantine—Alzheimer's disease	0.000762	0.00164	CcSEcCtD
Methylprednisolone—Syncope—Rivastigmine—Alzheimer's disease	0.00076	0.00164	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000753	0.00162	CcSEcCtD
Methylprednisolone—Convulsion—Memantine—Alzheimer's disease	0.000751	0.00162	CcSEcCtD
Methylprednisolone—Hypertension—Memantine—Alzheimer's disease	0.000748	0.00161	CcSEcCtD
Methylprednisolone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000745	0.00161	CcSEcCtD
Methylprednisolone—Hypersensitivity—Galantamine—Alzheimer's disease	0.000741	0.0016	CcSEcCtD
Methylprednisolone—Arthralgia—Memantine—Alzheimer's disease	0.000738	0.00159	CcSEcCtD
Methylprednisolone—Myalgia—Memantine—Alzheimer's disease	0.000738	0.00159	CcSEcCtD
Methylprednisolone—Anxiety—Memantine—Alzheimer's disease	0.000735	0.00159	CcSEcCtD
Methylprednisolone—Convulsion—Rivastigmine—Alzheimer's disease	0.000735	0.00158	CcSEcCtD
Methylprednisolone—Hypertension—Rivastigmine—Alzheimer's disease	0.000732	0.00158	CcSEcCtD
Methylprednisolone—Discomfort—Memantine—Alzheimer's disease	0.000729	0.00157	CcSEcCtD
Methylprednisolone—Hypotension—Donepezil—Alzheimer's disease	0.000728	0.00157	CcSEcCtD
Methylprednisolone—Myalgia—Rivastigmine—Alzheimer's disease	0.000722	0.00156	CcSEcCtD
Methylprednisolone—Arthralgia—Rivastigmine—Alzheimer's disease	0.000722	0.00156	CcSEcCtD
Methylprednisolone—Asthenia—Galantamine—Alzheimer's disease	0.000721	0.00156	CcSEcCtD
Methylprednisolone—Anxiety—Rivastigmine—Alzheimer's disease	0.000719	0.00155	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000717	0.00155	CcSEcCtD
Methylprednisolone—Confusional state—Memantine—Alzheimer's disease	0.000713	0.00154	CcSEcCtD
Methylprednisolone—Discomfort—Rivastigmine—Alzheimer's disease	0.000713	0.00154	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00071	0.00153	CcSEcCtD
Methylprednisolone—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000709	0.015	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CDK5—Alzheimer's disease	0.000708	0.015	CbGpPWpGaD
Methylprednisolone—Insomnia—Donepezil—Alzheimer's disease	0.000705	0.00152	CcSEcCtD
Methylprednisolone—Infection—Memantine—Alzheimer's disease	0.000703	0.00152	CcSEcCtD
Methylprednisolone—Paraesthesia—Donepezil—Alzheimer's disease	0.0007	0.00151	CcSEcCtD
Methylprednisolone—Confusional state—Rivastigmine—Alzheimer's disease	0.000698	0.00151	CcSEcCtD
Methylprednisolone—Shock—Memantine—Alzheimer's disease	0.000696	0.0015	CcSEcCtD
Methylprednisolone—Nervous system disorder—Memantine—Alzheimer's disease	0.000694	0.0015	CcSEcCtD
Methylprednisolone—Tachycardia—Memantine—Alzheimer's disease	0.00069	0.00149	CcSEcCtD
Methylprednisolone—Diarrhoea—Galantamine—Alzheimer's disease	0.000688	0.00148	CcSEcCtD
Methylprednisolone—Infection—Rivastigmine—Alzheimer's disease	0.000687	0.00148	CcSEcCtD
Methylprednisolone—Skin disorder—Memantine—Alzheimer's disease	0.000687	0.00148	CcSEcCtD
Methylprednisolone—Dyspepsia—Donepezil—Alzheimer's disease	0.000686	0.00148	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000684	0.00148	CcSEcCtD
Methylprednisolone—Shock—Rivastigmine—Alzheimer's disease	0.000681	0.00147	CcSEcCtD
Methylprednisolone—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000679	0.00146	CcSEcCtD
Methylprednisolone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000675	0.00146	CcSEcCtD
Methylprednisolone—Skin disorder—Rivastigmine—Alzheimer's disease	0.000672	0.00145	CcSEcCtD
Methylprednisolone—Fatigue—Donepezil—Alzheimer's disease	0.000672	0.00145	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000669	0.00144	CcSEcCtD
Methylprednisolone—Dizziness—Galantamine—Alzheimer's disease	0.000665	0.00143	CcSEcCtD
Methylprednisolone—Hypotension—Memantine—Alzheimer's disease	0.000661	0.00143	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—LEP—Alzheimer's disease	0.000652	0.0138	CbGpPWpGaD
Methylprednisolone—Hypotension—Rivastigmine—Alzheimer's disease	0.000647	0.0014	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000644	0.00139	CcSEcCtD
Methylprednisolone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000642	0.00139	CcSEcCtD
Methylprednisolone—Insomnia—Memantine—Alzheimer's disease	0.00064	0.00138	CcSEcCtD
Methylprednisolone—Vomiting—Galantamine—Alzheimer's disease	0.000639	0.00138	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000637	0.00137	CcSEcCtD
Methylprednisolone—Paraesthesia—Memantine—Alzheimer's disease	0.000635	0.00137	CcSEcCtD
Methylprednisolone—Rash—Galantamine—Alzheimer's disease	0.000634	0.00137	CcSEcCtD
Methylprednisolone—Dermatitis—Galantamine—Alzheimer's disease	0.000633	0.00137	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00063	0.00136	CcSEcCtD
Methylprednisolone—Headache—Galantamine—Alzheimer's disease	0.00063	0.00136	CcSEcCtD
Methylprednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—Alzheimer's disease	0.00063	0.0133	CbGpPWpGaD
Methylprednisolone—Insomnia—Rivastigmine—Alzheimer's disease	0.000626	0.00135	CcSEcCtD
Methylprednisolone—Dyspepsia—Memantine—Alzheimer's disease	0.000623	0.00134	CcSEcCtD
Methylprednisolone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000621	0.00134	CcSEcCtD
Methylprednisolone—Urticaria—Donepezil—Alzheimer's disease	0.000619	0.00134	CcSEcCtD
Methylprednisolone—Abdominal pain—Donepezil—Alzheimer's disease	0.000616	0.00133	CcSEcCtD
Methylprednisolone—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00061	0.0129	CbGpPWpGaD
Methylprednisolone—Fatigue—Memantine—Alzheimer's disease	0.00061	0.00132	CcSEcCtD
Methylprednisolone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000609	0.00131	CcSEcCtD
Methylprednisolone—Nausea—Galantamine—Alzheimer's disease	0.000597	0.00129	CcSEcCtD
Methylprednisolone—Fatigue—Rivastigmine—Alzheimer's disease	0.000597	0.00129	CcSEcCtD
Methylprednisolone—Feeling abnormal—Memantine—Alzheimer's disease	0.000583	0.00126	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000578	0.00125	CcSEcCtD
Methylprednisolone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000574	0.00124	CcSEcCtD
Methylprednisolone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00057	0.00123	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Alzheimer's disease	0.000568	0.012	CbGpPWpGaD
Methylprednisolone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000566	0.00122	CcSEcCtD
Methylprednisolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—Alzheimer's disease	0.000563	0.0119	CbGpPWpGaD
Methylprednisolone—Urticaria—Memantine—Alzheimer's disease	0.000562	0.00121	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—CREB1—Alzheimer's disease	0.00056	0.0118	CbGpPWpGaD
Methylprednisolone—Abdominal pain—Memantine—Alzheimer's disease	0.000559	0.00121	CcSEcCtD
Methylprednisolone—Asthenia—Donepezil—Alzheimer's disease	0.000559	0.00121	CcSEcCtD
Methylprednisolone—Pruritus—Donepezil—Alzheimer's disease	0.000551	0.00119	CcSEcCtD
Methylprednisolone—Urticaria—Rivastigmine—Alzheimer's disease	0.00055	0.00119	CcSEcCtD
Methylprednisolone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000547	0.00118	CcSEcCtD
Methylprednisolone—Triamcinolone—BCHE—Alzheimer's disease	0.000538	0.218	CrCbGaD
Methylprednisolone—Diarrhoea—Donepezil—Alzheimer's disease	0.000533	0.00115	CcSEcCtD
Methylprednisolone—Hypersensitivity—Memantine—Alzheimer's disease	0.000521	0.00112	CcSEcCtD
Methylprednisolone—Dizziness—Donepezil—Alzheimer's disease	0.000515	0.00111	CcSEcCtD
Methylprednisolone—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000515	0.0109	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00051	0.0011	CcSEcCtD
Methylprednisolone—Asthenia—Memantine—Alzheimer's disease	0.000507	0.00109	CcSEcCtD
Methylprednisolone—Pruritus—Memantine—Alzheimer's disease	0.0005	0.00108	CcSEcCtD
Methylprednisolone—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—Alzheimer's disease	0.000498	0.0105	CbGpPWpGaD
Methylprednisolone—Asthenia—Rivastigmine—Alzheimer's disease	0.000496	0.00107	CcSEcCtD
Methylprednisolone—Vomiting—Donepezil—Alzheimer's disease	0.000495	0.00107	CcSEcCtD
Methylprednisolone—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000491	0.0104	CbGpPWpGaD
Methylprednisolone—Rash—Donepezil—Alzheimer's disease	0.000491	0.00106	CcSEcCtD
Methylprednisolone—Dermatitis—Donepezil—Alzheimer's disease	0.000491	0.00106	CcSEcCtD
Methylprednisolone—Pruritus—Rivastigmine—Alzheimer's disease	0.00049	0.00106	CcSEcCtD
Methylprednisolone—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000488	0.0103	CbGpPWpGaD
Methylprednisolone—Headache—Donepezil—Alzheimer's disease	0.000488	0.00105	CcSEcCtD
Methylprednisolone—Diarrhoea—Memantine—Alzheimer's disease	0.000484	0.00104	CcSEcCtD
Methylprednisolone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000473	0.00102	CcSEcCtD
Methylprednisolone—Dizziness—Memantine—Alzheimer's disease	0.000468	0.00101	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000463	0.00979	CbGpPWpGaD
Methylprednisolone—Nausea—Donepezil—Alzheimer's disease	0.000463	0.000998	CcSEcCtD
Methylprednisolone—Dizziness—Rivastigmine—Alzheimer's disease	0.000458	0.000987	CcSEcCtD
Methylprednisolone—Vomiting—Memantine—Alzheimer's disease	0.00045	0.00097	CcSEcCtD
Methylprednisolone—Medroxyprogesterone Acetate—ESR1—Alzheimer's disease	0.000448	0.181	CrCbGaD
Methylprednisolone—Rash—Memantine—Alzheimer's disease	0.000446	0.000962	CcSEcCtD
Methylprednisolone—Dermatitis—Memantine—Alzheimer's disease	0.000446	0.000961	CcSEcCtD
Methylprednisolone—Headache—Memantine—Alzheimer's disease	0.000443	0.000956	CcSEcCtD
Methylprednisolone—Vomiting—Rivastigmine—Alzheimer's disease	0.00044	0.000949	CcSEcCtD
Methylprednisolone—NR3C1—Endoderm Differentiation—APP—Alzheimer's disease	0.000439	0.00929	CbGpPWpGaD
Methylprednisolone—Rash—Rivastigmine—Alzheimer's disease	0.000436	0.000941	CcSEcCtD
Methylprednisolone—Dermatitis—Rivastigmine—Alzheimer's disease	0.000436	0.00094	CcSEcCtD
Methylprednisolone—Headache—Rivastigmine—Alzheimer's disease	0.000433	0.000935	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—LRRK2—Alzheimer's disease	0.000429	0.00907	CbGpPWpGaD
Methylprednisolone—Nausea—Memantine—Alzheimer's disease	0.00042	0.000907	CcSEcCtD
Methylprednisolone—Dexamethasone—NOS2—Alzheimer's disease	0.000412	0.166	CrCbGaD
Methylprednisolone—Nausea—Rivastigmine—Alzheimer's disease	0.000411	0.000887	CcSEcCtD
Methylprednisolone—NR3C1—Circadian Clock—PPARGC1A—Alzheimer's disease	0.00041	0.00868	CbGpPWpGaD
Methylprednisolone—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000408	0.00864	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptors—ESR1—Alzheimer's disease	0.000402	0.0085	CbGpPWpGaD
Methylprednisolone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—Alzheimer's disease	0.000402	0.0085	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000394	0.00833	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000394	0.00833	CbGpPWpGaD
Methylprednisolone—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000393	0.00831	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000382	0.00809	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000381	0.00806	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Alzheimer's disease	0.000381	0.00806	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000377	0.00798	CbGpPWpGaD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000376	0.00795	CbGpPWpGaD
Methylprednisolone—NR3C1—Circadian Clock—MEF2C—Alzheimer's disease	0.00037	0.00783	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptors—PPARG—Alzheimer's disease	0.000367	0.00776	CbGpPWpGaD
Methylprednisolone—Ciclesonide—CYP2D6—Alzheimer's disease	0.000365	0.148	CrCbGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.000353	0.00747	CbGpPWpGaD
Methylprednisolone—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.00034	0.00719	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000335	0.00708	CbGpPWpGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.000322	0.0068	CbGpPWpGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.00032	0.00677	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—CP—Alzheimer's disease	0.000319	0.00675	CbGpPWpGaD
Methylprednisolone—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000318	0.00672	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.000318	0.00672	CbGpPWpGaD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—Alzheimer's disease	0.000315	0.00666	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000315	0.00666	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00031	0.00656	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000309	0.00653	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—Alzheimer's disease	0.000301	0.00638	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.00029	0.00613	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000282	0.00598	CbGpPWpGaD
Methylprednisolone—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000282	0.00597	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.000279	0.00591	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.000272	0.00575	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—TF—Alzheimer's disease	0.000271	0.00574	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—BAX—Alzheimer's disease	0.000269	0.0057	CbGpPWpGaD
Methylprednisolone—NR3C1—Circadian Clock—CREB1—Alzheimer's disease	0.000269	0.00569	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—PLAU—Alzheimer's disease	0.000262	0.00554	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—ENO1—Alzheimer's disease	0.00026	0.0055	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000257	0.00543	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000254	0.00537	CbGpPWpGaD
Methylprednisolone—Triamcinolone—PTGS2—Alzheimer's disease	0.000248	0.1	CrCbGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—ESR1—Alzheimer's disease	0.000247	0.00522	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—NOTCH1—Alzheimer's disease	0.000244	0.00516	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—Alzheimer's disease	0.000243	0.00515	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000238	0.00505	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000232	0.00491	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000232	0.00491	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000232	0.0049	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CREB1—Alzheimer's disease	0.000222	0.00469	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.000219	0.00464	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CCL2—Alzheimer's disease	0.000217	0.00459	CbGpPWpGaD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000215	0.00455	CbGpPWpGaD
Methylprednisolone—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000209	0.00443	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—PPARGC1A—Alzheimer's disease	0.000206	0.00436	CbGpPWpGaD
Methylprednisolone—Betamethasone—PTGS2—Alzheimer's disease	0.000203	0.0821	CrCbGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.000197	0.00418	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—Alzheimer's disease	0.000197	0.00417	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CREB1—Alzheimer's disease	0.000195	0.00413	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Alzheimer's disease	0.00019	0.00401	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.000189	0.00399	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—LPL—Alzheimer's disease	0.000188	0.00397	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—MEF2C—Alzheimer's disease	0.000186	0.00394	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000185	0.00391	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000178	0.00377	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000173	0.00366	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.00017	0.00359	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000167	0.00354	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000166	0.00352	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000165	0.00348	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000164	0.00347	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000162	0.00343	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000161	0.0034	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—LEP—Alzheimer's disease	0.000157	0.00333	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL1A—Alzheimer's disease	0.000154	0.00326	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000154	0.00325	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000146	0.00309	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000146	0.00309	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—LEP—Alzheimer's disease	0.000145	0.00308	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000144	0.00304	CbGpPWpGaD
Methylprednisolone—Dexamethasone—CYP2D6—Alzheimer's disease	0.000141	0.0569	CrCbGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.00014	0.00296	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PHF1—Alzheimer's disease	0.000139	0.00295	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000137	0.00291	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—PPARG—Alzheimer's disease	0.000137	0.0029	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—NOS2—Alzheimer's disease	0.000135	0.00287	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—CREB1—Alzheimer's disease	0.000135	0.00286	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—INS—Alzheimer's disease	0.000134	0.00284	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000133	0.00281	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Alzheimer's disease	0.000133	0.00281	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000133	0.00281	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—TGFB1—Alzheimer's disease	0.000131	0.00277	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IGF1—Alzheimer's disease	0.00013	0.00275	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000129	0.00273	CbGpPWpGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000129	0.00273	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	0.000128	0.00271	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—CREB1—Alzheimer's disease	0.000125	0.00264	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000121	0.00255	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000119	0.00251	CbGpPWpGaD
Methylprednisolone—Dexamethasone—PTGS2—Alzheimer's disease	0.000118	0.0478	CrCbGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000117	0.00247	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TP53—Alzheimer's disease	0.000105	0.00223	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000105	0.00222	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000103	0.00219	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000101	0.00214	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	9.82e-05	0.00208	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL6—Alzheimer's disease	9.64e-05	0.00204	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—Alzheimer's disease	9.28e-05	0.00196	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—TFAM—Alzheimer's disease	8.98e-05	0.0019	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	8.67e-05	0.00183	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	8.65e-05	0.00183	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	8.62e-05	0.00182	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—Alzheimer's disease	8.49e-05	0.0018	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	8.03e-05	0.0017	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	8.01e-05	0.00169	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	7.91e-05	0.00167	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	7.91e-05	0.00167	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	7.85e-05	0.00166	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	7.83e-05	0.00166	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	7.8e-05	0.00165	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	7.44e-05	0.00157	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	7.36e-05	0.00156	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	7.34e-05	0.00155	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	7.3e-05	0.00154	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TNF—Alzheimer's disease	7.28e-05	0.00154	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	7.2e-05	0.00152	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—DHCR24—Alzheimer's disease	6.85e-05	0.00145	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	6.8e-05	0.00144	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	6.29e-05	0.00133	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	6.24e-05	0.00132	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	5.93e-05	0.00126	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IL6—Alzheimer's disease	5.87e-05	0.00124	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	5.82e-05	0.00123	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CA4—Alzheimer's disease	5.82e-05	0.00123	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	5.49e-05	0.00116	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	5.47e-05	0.00116	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	5.41e-05	0.00114	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	5.41e-05	0.00114	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	5.34e-05	0.00113	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	5.3e-05	0.00112	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	5.19e-05	0.0011	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	5.13e-05	0.00109	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	5.08e-05	0.00107	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	5.01e-05	0.00106	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	5e-05	0.00106	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLD3—Alzheimer's disease	4.95e-05	0.00105	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	4.75e-05	0.001	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	4.6e-05	0.000973	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	4.57e-05	0.000967	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	4.48e-05	0.000948	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ND1—Alzheimer's disease	4.41e-05	0.000934	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	4.26e-05	0.000901	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	4.22e-05	0.000893	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	3.95e-05	0.000836	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.63e-05	0.000768	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CA4—Alzheimer's disease	3.59e-05	0.000759	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	3.37e-05	0.000714	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.35e-05	0.00071	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	3.22e-05	0.000681	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.2e-05	0.000676	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.08e-05	0.000651	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.05e-05	0.000645	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.92e-05	0.000619	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.87e-05	0.000608	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TPI1—Alzheimer's disease	2.84e-05	0.000602	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CHAT—Alzheimer's disease	2.84e-05	0.000602	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.82e-05	0.000596	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MAOB—Alzheimer's disease	2.73e-05	0.000577	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.72e-05	0.000575	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ESR1—Alzheimer's disease	2.64e-05	0.000559	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GAPDH—Alzheimer's disease	2.62e-05	0.000555	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	2.55e-05	0.00054	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—A2M—Alzheimer's disease	2.53e-05	0.000536	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.53e-05	0.000536	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARG—Alzheimer's disease	2.41e-05	0.00051	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ACHE—Alzheimer's disease	2.2e-05	0.000466	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—INPP5D—Alzheimer's disease	2.18e-05	0.000461	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.14e-05	0.000453	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS1—Alzheimer's disease	2.07e-05	0.000437	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ENO1—Alzheimer's disease	2.07e-05	0.000437	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	2.03e-05	0.000429	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.92e-05	0.000406	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.81e-05	0.000383	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.76e-05	0.000372	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.75e-05	0.000371	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.75e-05	0.000371	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.68e-05	0.000355	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.62e-05	0.000342	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.56e-05	0.00033	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.51e-05	0.00032	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.51e-05	0.000319	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LPL—Alzheimer's disease	1.38e-05	0.000292	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.36e-05	0.000287	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.34e-05	0.000284	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.27e-05	0.000269	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.27e-05	0.000269	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.25e-05	0.000264	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.24e-05	0.000263	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.18e-05	0.00025	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.16e-05	0.000245	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOE—Alzheimer's disease	1.16e-05	0.000244	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.14e-05	0.000242	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.12e-05	0.000236	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.08e-05	0.000229	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.01e-05	0.000213	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—INS—Alzheimer's disease	9.87e-06	0.000209	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AKT1—Alzheimer's disease	9.53e-06	0.000202	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	9.33e-06	0.000197	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	9.29e-06	0.000196	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NOS3—Alzheimer's disease	8.66e-06	0.000183	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LPL—Alzheimer's disease	8.49e-06	0.00018	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS2—Alzheimer's disease	7.92e-06	0.000168	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	7.65e-06	0.000162	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	7.14e-06	0.000151	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOE—Alzheimer's disease	7.12e-06	0.000151	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	7.05e-06	0.000149	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	6.2e-06	0.000131	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—INS—Alzheimer's disease	6.08e-06	0.000129	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	5.33e-06	0.000113	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	4.88e-06	0.000103	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKT1—Alzheimer's disease	3.98e-06	8.42e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.45e-06	5.19e-05	CbGpPWpGaD
